Invitation to Presentation of Herantis Pharma’s 2H and Full Year Report 2021
Herantis Pharma Plc, Press Release, 7 February 2022 at 09:00 EET Herantis Pharma Plc (“Herantis”), developing disease modifying therapies for Parkinson’s disease, announced today that the company will report 2H and Full Year report 2021 and hold a live webinar (in English) for investors, analysts and media on: Thursday, March 3[rd], 2022, at 10:00 EET / 9:00 CET. Herantis will publish the company’s 2H and Full Year 2021 report on March 3, 2022, at 8:00 EET /7:00 CET. The management will present Herantis and comment on the 2H and Full Year 2021 Report followed by a live Q&A